Cytological Ki-67 in pancreatic endocrine tumours: An opportunity for pre-operative grading

71Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

The cytological Ki-67 expression measured on cytological samples collected by endoscopic ultrasonography-guided fine needle aspiration cytology (EUS-FNAC) may provide pre-operative indications for pancreatic endocrine tumours (PETs) management. The aim of our study was to assess reliability of Ki-67 expression measured on cytological samples obtained by EUS-FNAC in patients with PETs. Eighteen patients with PETs underwent EUS-FNAC before surgery. Ki-67 expression was measured on FNACs and on histological sections. Using a cut-off of 2%, percent agreement of Ki-67 expression on cytological and histological samples was 89% (k-statistic: 0.78, 95% confidence intervals (95% CI): 0.5,1.0). Using cut-off values of 2 and 10%, percent agreement was 78% (k-statistic: 0.65, 95% CI: 0.3, 0.9). Ki-67 expression measured on cytological samples obtained by EUS-FNAC before surgery showed good agreement with that measured on histological samples. © 2008 Society for Endocrinology.

Cite

CITATION STYLE

APA

Piani, C., Franchi, G. M., Cappelletti, C., Scavini, M., Albarello, L., Zerbi, A., … Manzoni, M. F. (2008). Cytological Ki-67 in pancreatic endocrine tumours: An opportunity for pre-operative grading. Endocrine-Related Cancer, 15(1), 175–181. https://doi.org/10.1677/ERC-07-0126

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free